Diffusion Pharmaceuticals Inc. is on the Cruelty Free Investing list for exploiting animals because the company does animal testing for some of their medical analysis and clinical research.
The company in the following press release announced, “The successful completion of dosing of two animal toxicology studies required by the U.S. Food and Drug Administration (FDA) to support Diffusion’s planned Phase 3 clinical trial testing its lead molecule trans sodium crocetinate (TSC) in newly diagnosed Glioblastoma (GBM) patients.” Read the full article.
Diffusion Pharmaceuticals Inc. is a clinical stage biotechnology company. The Company is focused on improving the effectiveness of current standard-of-care treatments, including radiation therapy and chemotherapy, for cancer patients. Diffusion operates within the United States. [Source: Bloomberg]
Company Website: http://www.diffusionpharma.com